Sign up for free insights newsletter
ME

Medios AG

MEDOFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$50.00
+0.00%
End of day
Market Cap

$1.23B

P/E Ratio

73.53

Employees

999

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Ulcer0.000.000.000.000.00

Medios AG (MEDOF) Price Performance

Medios AG (MEDOF) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at $50.00.

Over the past year, MEDOF has traded between a low of $50.00 and a high of $50.00.

Medios AG has a market capitalization of $1.23B, with a price-to-earnings ratio of 73.53.

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is headquartered in Berlin, Germany.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$2.01B
EBITDA
$76.02M
Profit Margin
1.09%
EPS (TTM)
0.68
Book Value
24.06

Technical Indicators

52 Week High
$50.00
52 Week Low
$13.64
50 Day MA
$50.00
200 Day MA
$50.00
Beta
1.10

Valuation

Trailing P/E
73.53
Forward P/E
N/A
Price/Sales
0.61
Price/Book
3.25
Enterprise Value
$565.24M